Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 512483, 6 pages
http://dx.doi.org/10.1155/2013/512483
Research Article

Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles

1Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou 310009, China
2Department of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, No. 866 Yuhangtang Road, Hangzhou 310058, China

Received 22 September 2013; Accepted 8 November 2013

Academic Editor: Horia Stefãnescu

Copyright © 2013 Ri-Sheng Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z. Zhang, J. Li, S. Wu et al., “Cine-MRI and 31P-MRS for evaluation of myocardial energy metabolism and function following coronary artery bypass graft,” Magnetic Resonance Imaging, vol. 28, no. 7, pp. 936–942, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Kugel, H.-J. Wittsack, F. Wenzel, D. Stippel, W. Heindel, and K. Lackner, “Non-invasive determination of metabolite concentrations in human transplanted kidney in vivo by 31P MR spectroscopy,” Acta Radiologica, vol. 41, no. 6, pp. 634–641, 2000. View at Google Scholar · View at Scopus
  3. I. R. Corbin, L. N. Ryner, H. Singh, and G. Y. Minuk, “Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis,” The American Journal of Physiology: Gastrointestinal and Liver Physiology, vol. 287, no. 2, pp. 379–384, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. K. P. Lim, N. Patel, G. Hamilton, J. V. Hajnal, R. D. Goldin, and S. D. Taylor-Robinson, “The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C,” Hepatology, vol. 37, no. 4, pp. 788–794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. I. R. Corbin, R. Buist, J. Peeling, M. Zhang, J. Uhanova, and G. Y. Minuk, “Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease,” Gut, vol. 52, no. 7, pp. 1046–1053, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Morse, D. Carroll, S. Day et al., “Characterization of Breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway,” NMR in Biomedicine, vol. 22, no. 1, pp. 114–127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. O. Oyewumi and R. J. Mumper, “Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles,” International Journal of Pharmaceutics, vol. 251, no. 1-2, pp. 85–97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. Q. Wang, L. Zhang, W. Hu et al., “Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery,” Nanomedicine, vol. 6, no. 2, pp. 371–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. F.-L. Mi, Y.-Y. Wu, Y.-L. Chiu et al., “Synthesis of a novel glycoconjugated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells,” Biomacromolecules, vol. 8, no. 3, pp. 892–898, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Zhang, X. G. Chen, W. B. Peng, and C. S. Liu, “Uptake of oleoyl-chitosan nanoparticles by A549 cells,” Nanomedicine, vol. 4, no. 3, pp. 208–214, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Kean, S. Roth, and M. Thanou, “Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency,” Journal of Controlled Release, vol. 103, no. 3, pp. 643–653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. F.-Q. Hu, M.-D. Zhao, H. Yuan, J. You, Y.-Z. Du, and S. Zeng, “A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies,” International Journal of Pharmaceutics, vol. 315, no. 1-2, pp. 158–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Y. Wu and C. H. Wu, “Receptor-mediated delivery of foreign genes to hepatocytes,” Advanced Drug Delivery Reviews, vol. 29, no. 3, pp. 243–248, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. E. I. Rigopoulou, D. Roggenbuck, D. S. Smyk et al., “Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: lost and found,” Autoimmunity Reviews, vol. 12, no. 2, pp. 260–269, 2012. View at Publisher · View at Google Scholar
  15. T. Ishihara, A. Kano, K. Obara et al., “Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates,” Journal of Controlled Release, vol. 155, no. 1, pp. 34–39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. H. N. Yik, A. Saxena, J. A. Weigel, and P. H. Weigel, “Nonpalmitoylated human asialoglycoprotein receptors recycle constitutively but are defective in coated pit-mediated endocytosis, dissociation, and delivery of ligand to lysosomes,” The Journal of Biological Chemistry, vol. 277, no. 43, pp. 40844–40852, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. X. L. Zhu, Y. Z. Du, R. S. Yu et al., “Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15755–15766, 2013. View at Google Scholar
  18. Z. Ma and L.-Y. Lim, “Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles,” Pharmaceutical Research, vol. 20, no. 11, pp. 1812–1819, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. Solga, A. Horska, J. M. Clark, and A. M. Diehl, “Hepatic 31P magnetic resonance spectroscopy: a hepatologist's user guide,” Liver International, vol. 25, no. 3, pp. 490–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. I. R. Corbin, R. Buist, V. Volotovskyy, J. Peeling, M. Zhang, and G. Y. Minuk, “Regenerative activity and liver function following partial hepatectomy in the rat using 31P-MR spectroscopy,” Hepatology, vol. 36, no. 2, pp. 345–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. I. R. Corbin, R. Buist, J. Peeling, M. Zhang, J. Uhanova, and G. Y. Minuk, “Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure,” Journal of Investigative Medicine, vol. 51, no. 1, pp. 42–49, 2003. View at Google Scholar · View at Scopus
  22. R.-S. Yu, L. Hao, F. Dong et al., “Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits,” World Journal of Gastroenterology, vol. 15, no. 22, pp. 2723–2730, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S.-J. Seo, I.-Y. Kim, Y.-J. Choi, T. Akaike, and C.-S. Cho, “Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold,” Biomaterials, vol. 27, no. 8, pp. 1487–1495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. H. Kim, I. K. Park, J. W. Nah, Y. J. Choi, and C. S. Cho, “Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier,” Biomaterials, vol. 25, no. 17, pp. 3783–3792, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Maitani, K. Kawano, K. Yamada, T. Nagai, and K. Takayama, “Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells,” Journal of Controlled Release, vol. 75, no. 3, pp. 381–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Gao, J. Chen, X. Xu et al., “Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting,” International Journal of Pharmaceutics, vol. 255, no. 1-2, pp. 57–68, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Yin, L. Ying, P.-C. Zhang et al., “High density of immobilized galactose ligand enhances hepatocyte attachment and function,” Journal of Biomedical Materials Research A, vol. 67, no. 4, pp. 1093–1104, 2003. View at Google Scholar · View at Scopus
  28. K. Leung, Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US), Bethesda (MD), 2004–2013, http://www.ncbi.nlm.nih.gov/books/NBK5330/.
  29. A. Akinc, W. Querbes, S. De et al., “Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms,” Molecular Therapy, vol. 18, no. 7, pp. 1357–1364, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. E. B. Dizhe, B. N. Akifiev, B. V. Missul et al., “Receptor-mediated transfer of DNA-galactosylated poly-L-lysine complexes into mammalian cells in vitro and in vivo,” Biochemistry, vol. 66, no. 1, pp. 55–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Murao, M. Nishikawa, C. Managit et al., “Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition,” Pharmaceutical Research, vol. 19, no. 12, pp. 1808–1814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Xu, L. Chen, W. Gu et al., “The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma,” Biomaterials, vol. 30, no. 2, pp. 226–232, 2009. View at Publisher · View at Google Scholar · View at Scopus